Zhongyuan Biotechnology Holdings Co., Ltd. plans to upgrade from the OTC market in the United States to the NASDAQ main board market, becoming the first company to apply for registration with the China Securities Regulatory Commission.

In the past two weeks or so, five SPACs were newly established this year and applied for IPOs before mid June.

Dashuyun Group, a Chinese high-end personal care product full chain conglomerate, successfully landed on the NASDAQ main board market in the United States in 8 months, leveraging the Chinese background SPAC.

Taifeng Culture, the largest contemporary Chinese painting trading intermediary in China, plans to list on NASDAQ in the United States through SPAC in the second half of 2024.

The China Securities Regulatory Commission has issued regulatory requirements for domestic enterprises to transfer from overseas over-the-counter markets to overseas stock exchanges for overseas issuance and listing.

In the first quarter of 2024, with the continuous introduction of favorable policies, the listing of Chinese concept stocks in the United States showed a trend of recovery and recovery.

The media technology company under former US President Trump was able to go public at lightning speed through SPAC, making Trump one of Bloomberg's top 400 global billionaires.

On January 24, 2024, the US Securities and Exchange Commission (SEC) passed the SPAC regulatory regulations with a 3:2 vote. The new SPAC regulations will further promote the development and regulation of SPAC listings.